‌Journal Information

Innovation Immunology

Online ISSN: request pending

Print    ISSN: request pending

Publishing model:  Open Access

DOI Prefix: 10.62762/IMMUNOL

Aims & Scope

The Innovation Immunology is dedicated to advancing the understanding of immunological mechanisms and their applications in health, disease, and biotechnology. The journal aims to publish cutting-edge research, innovative methodologies, and transformative insights across all areas of immunology, including immune system development, immune responses in disease, immunotherapy, vaccine development, and systems immunology. We welcome interdisciplinary studies that integrate immunology with emerging fields such as artificial intelligence, synthetic biology, and precision medicine. By fostering the exchange of novel ideas and promoting collaboration, Innovation Immunology seeks to drive the discovery of impactful solutions to global health challenges.

Publication Frequency

Quarterly

Ownership

The journal is owned by Institute of Central Computation and Knowledge.

Archiving

All journals published by ICCK are archived in Portico, which provides permanent digital archiving for scholarly journals.

Ethics Statement

ICCK is responsible for implementing rigorous peer review and strict ethical policies and standards to ensure that high quality scientific work is added to the field of scholarly publishing. ICCK takes such publishing ethics issues very seriously, and our editors are trained to enforce COPE's Core Practices and Guidelines, with a zero-tolerance policy for plagiarism, data falsification, and other behaviours. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.